A-Alpha Bio is building a high-resolution model of biology by measuring protein interactions.

A-Alpha leverages its platform technology AlphaSeq to generate high-quality protein interaction data at scale, enabling the discovery of better drugs faster.

• Industry

  • AI & Machine Learning
  • Biotechnology
  • Health + Tech

• Milestones

  • Lux investment: 2021

• Founders

  • David Younger
  • Randolph Lopez

  LUX Partners

  • Zavain Dar

• Latest Tweets

  • ICYMI: A comprehensive look at our unique history and our exciting future! Thanks @frankvinluan & @medcitynews!… https://t.co/DMAYV7Pehj@AAlphaBio - 04:31 PM Sep 15th
  • A fantastic piece on our Series A funding and what this means for us moving forward! https://t.co/Cbs2k88DHC@AAlphaBio - 04:39 PM Sep 10th
  • A fantastic piece on our Series A funding and what this means for us moving forward! https://t.co/Cbs2k88DHC@AAlphaBio - 04:40 PM Sep 9th